Demand for estrogen patches surged 26% after the FDA removed a black box warning on hormone therapy in 2025 ...

(HealthDay News) — For men with locally advanced prostate cancer, transdermal estradiol (tE2) patches are noninferior to luteinizing hormone-releasing hormone (LHRH) agonists as androgen deprivation ...

A timely 2026 release highlighting growing consumer research interest in skin-absorption wellness formats, ingredient themes, ...

Delhi, March 17, 2025 (GLOBE NEWSWIRE) -- Global Transdermal Patch Market Opportunity, Patch Dosage, Price & Clinical Trials Insight 2030 Report Highlights & Findings: The global market for ...

Consumer Search Activity Surges as Questions Mount Over Berberine Patch Ingredients, Transdermal Delivery Claims, and Company Background — Publicly Available Information Compiled for 2026Wayne, NJ, ...

United States The type of adhesive patches known as transdermal patches is therapeutic. By utilizing transdermal technology and the diffusion technique, they assist in delivering a predetermined dose ...

More women are seeking treatment for menopause and perimenopause, driving a shortage of estrogen patches, one of the most ...

Purisaki Berberine Patches belong to this new category. These are patches that are meant to deliver ingredients slowly over ...

Nutriband has selected the commercial worldwide brand name for its lead product, an abuse deterrent fentanyl transdermal system, and will submit ...

Restless legs syndrome (RLS) is a chronic, usually idiopathic disorder characterized by uncontrollable urges to move the legs or arms at night along with unpleasant sensations in the affected limbs.